Genetic subcutaneous tissue disorder

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

Regulatory Watchboard

10 events

Apr 2026A Clinical Study to Evaluate SM17 for Atopic Dermatitis

SinoMab BioScience Ltd — PHASE2

TrialNOT YET RECRUITING

Mar 2026A Phase 1 Study of GS101 Injection

Jiangsu Genscend Biopharmaceutical Co., Ltd — PHASE1

TrialRECRUITING

Dec 2025Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Biopharma Plasma LLC — PHASE3

TrialRECRUITING

Dec 2025A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Guangdong Hengrui Pharmaceutical Co., Ltd — PHASE1

TrialNOT YET RECRUITING

Aug 2025A Study Evaluating TRIV-509 in Atopic Dermatitis

Triveni Bio — PHASE2

TrialRECRUITING

Jan 2025A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Sanofi — PHASE2

TrialACTIVE NOT RECRUITING

Aug 2024A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

AbbVie — PHASE3

TrialRECRUITING

Aug 2024A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

AbbVie — PHASE2

TrialRECRUITING

Aug 2024Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Oneness Biotech Co., Ltd. — PHASE2

TrialRECRUITING

May 2024A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Sanofi — PHASE3

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Genetic subcutaneous tissue disorder.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Genetic subcutaneous tissue disorder.
Search all trials →

Search clinical trials for Genetic subcutaneous tissue disorder →

Recent News & Research

No recent news articles indexed yet for Genetic subcutaneous tissue disorder.
Search PubMed for Genetic subcutaneous tissue disorder →

Browse all Genetic subcutaneous tissue disorder news →

Specialist Network

Top 6 by expertise

Global Clinical Program Director

CSL Behring

Score 175 trials

Chia-Yu Chu

National Taiwan University Hospital

Score 91 trial65 pubs

Scott R Plotkin, M.D

Massachusetts General Hospital

📍 BUFFALO, NY

Score 81 trial61 pubs

Hendrik Wolf, PhD

ALK-SCHERAX Arzneimittel GmbH

Wolfhart Kreuz, PD Phd

Centre of Paediatrics III, Department of Haematology, Haemostaseology and Oncology, Comprehensive Care Centre for Thrombosis and Haemostasis, Johann-Wolfgang-Goethe-University Hospital

Alexander Kapp, MD, Prof.

Hannover Medical School

📍 ARLINGTON, VA

View all Genetic subcutaneous tissue disorder specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles